Who we are

Hej!
Welcome to PharmaLex Sweden

The Swedish team is comprised of dedicated professionals with backgrounds in the pharmaceutical industry, the pharmacy profession and academic research institutes. Our ambition is to produce creative, high-quality work meeting the highest standards of scientific rigor and real-world applicability.

 

  • According to therapeutic area, business potential, and company resources, we support our clients within health economics, reimbursement, real-world evidence, and market access strategy, as well as local PV/REG consultancy.

 

  • The team have in-depth knowledge of the Nordic market culture and authorities` expectations, while also providing the know-how to assist our Nordic clients in accessing mature international markets.

 

  • As part of the global PharmaLex group, PharmaLex Sweden is your local point of contact reaching the entire PharmaLex service portfolio, servicing more than 600 national and global companies

Local Contact

  • Åsa Pihlblad
    Country Manager - PharmaLex Sweden PharmaLex Sweden Medicinaregatan 8B
    Gothenburg
    SE-413 90
    Sweden    +46 31 724 22 01
Download Terms and Conditions
Explore PharmaLex Market Access offersEarly Phase Modeling InfographicVirtual GxP AuditsReal World Evidence Fact Flyer
Auditing-services

PharmaLex.perts to guide you for HTA advice that makes a difference

Since 2003, PharmaLex Sweden, formerly known as Nordic Health Economics, offers highly qualified health-economic services throughout the development process of pharmaceuticals and medical technology-products.

We start by offering strategic advice in the early stages of product development, on how product opportunities and challenges could be addressed to optimize the possibilities for inclusion into reimbursement schemes. We then follow this by developing the core material in preparation of reimbursement applications, and if applicable, also including collection of Real-World-Evidence to support the cost-effectiveness of the product. We have an unparalleled base of knowledge how to effectively develop the appropriate evidence according to legislation and policies of the boards in the respective countries, and how to communicate the results in a manner that clearly presents relevant information and the validity of the results.

Get in touch to see how we can be of service.

Related News

What our clients say about us

We are working with a number of large pharma companies and are looking to create a consortium of partners to collect feedback on expertise, availability and outcomes. If you would be interested in joining our consortium, please contact us on contact@pharmalex.com.

  • What was especially important to me was their ability to get a team, with the right experience, together so quickly.

    Mid-size Biotech
    Head of Outsourcing

  • Pharmalex provided the resources we needed to compile Investigational Medicinal Product Dossiers for our biological products. The dossiers were delivered on time with the trusted quality we expected

    Small US Biopharmaceutical Company
    Sr Director Regulatory Affairs CMC

  • I just wanted to let you know that the recent EU Codes webinar was excellent. Rina presented a very complex and grey topic in the most clear and digestible manner – a sign of a true expert. The questions in the Q&A were sometimes a little ambiguous but Rina gave clear and relevant answers that provided real clarity.

    Richard Blackwell
    Medical Team Leader, Multi Tumor Franchise Roche Products Ltd

  • Provided honest feedback and collaborative working solutions to obstacles

    South Korea based medium sized company
    Manager